With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1334177-86-4,1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oic acid,as a common compound, the synthetic route is as follows.
EDCI (56 mg, 0.29 mmol) was added to a stirred solution of MAL-dPEG8-acid (172 mg,0.29 mmol, Stratech Scientific Limited) and the amine 110 (261 mg, 0.26 mmol) in dry DCM(10 mL) at room temperature. The reaction mixture was stirred under an argon atmospherefor 2.5 hours at which point analysis by LC/MS showed complete conversion to desiredproduct at retention time 1 .38 minutes, ES+ mlz 1585 [M+ Na], 1563 [M+ H].Thereaction mixture was diluted with DCM (30 mL) and washed with H20 (20 mL), brine (2 x20 mL), dried (Mg504), filtered and evaporated in vacuo to provide the crude product. Purification by lsoleraTM (DCM/MeOH, SNAP Ultra 25 g, 75 mL per minute) gave the amideIll (eluting at 91% DCM/MeOH) as a white foam (277 mg, 67% yield).
1334177-86-4 1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oic acid 51340955, apyrrolines compound, is more and more widely used in various.
Reference£º
Patent; MEDIMMUNE LIMITED; HOWARD, Philip Wilson; GREGSON, Stephen John; (207 pag.)WO2018/192944; (2018); A1;,
Pyrroline – Wikipedia
1-Pyrroline | C4H7N – PubChem